2025³â 08¿ù 08ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92587°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...

GS25 ¡®»ý°úÀÏ ½º¹«µð¡¯ ¿î¿µÁ¡ ±âÁØ Àüü ÆÇ¸Å·® 3À§

2030 ¼¼´ë°¡ °í°´ 69.5%
GS25°¡ ¾÷°è ÃÖÃÊ·Î ¼±º¸ÀÎ »ý°úÀÏ ½º¹«µð Àü¿ë ±â±â GS¸®Å×ÀÏÀÌ ¿î¿µÇÏ´Â ÆíÀÇÁ¡ GS25°¡ º»°ÝÀûÀÎ ¹«´õÀ§¸¦ ¸Â¾Æ ÃÖ±Ù 2ÁÖ°£(6/23~7/6) ‘»ý°úÀÏ ½º¹«µð’ ¿î¿µ Á¡Æ÷ 20¿© °÷À» ´ë»óÀ¸·Î ÆÇ¸Å µ¥ÀÌÅ͸¦ ºÐ¼®ÇÑ °á°ú »ý°úÀÏ ½º¹«µð°¡ ‘Ä«Æä25 ¾Æ¸Þ¸®Ä«³ë’, ‘ÄÅ ¾óÀ½’¿¡ À̾î Àüü ÆÇ¸Å·® 3À§(´ã¹è Á¦¿Ü)¿¡ µî±ØÇÑ °ÍÀ¸·Î ºÐ¼®µÆ´Ù. GS25´Â Áö³­ÇØ 12¿ù ÆíÀÇÁ¡ ¾÷°è ÃÖÃÊ·Î Á÷¿µÁ¡ ÇѰ÷À» ÅëÇØ Áï¼® »ý°úÀÏ ½º¹«µð¸¦ ¼±º¸¿´´Ù. ÃֽŠ¸Ô°Å¸® Æ®·»µå¸¦ ¼±Á¡ÇϰíÀÚ ÆíÀÇÁ¡ Ư¼º¿¡ ¸Â´Â Àü¿ë ±â±â ...
LG Electronics India Limited Begins Construction of Its Thir... (2025-05-23)
HMM, ¿µ¾÷ÀÌÀÍ·ü 30%¡¦ ±Û·Î¹ú ½ÃÀå¿¡¼­ °æÀï·Â ÀÔÁõ (2025-02-20)
Çѱ¹»ìÀÌ ¿øÇÏ´Â ¿Ü±¹ÀÎ À̰ø¡¤ÀÇ¾à ¹Ú»ç, ó¿ì´Â ¡®±Û½ê¡¯ (2025-02-20)
¡®¿µ±¹ ÆÐ¹Ð¸®¡¯ À¯ÇýÀ±X»ù, ¡®ÇÖ ÅÓ º¸Æ®¡¯±îÁö¡®Âð ·±´õ³Ê¡¯ ... (2024-12-15)
Çö´ë·ÎÅÛ, ¸ð·ÎÄÚ 2Ãþ Àüµ¿Â÷ »ç¾÷ ¼öÁÖ (2025-03-17)
½ºÆÐ·Î¿ì, û³âÀÏÀÚ¸® °­¼Ò±â¾÷ ¼±Á¤ (2025-03-03)
¡®µ¹½Ì±ÛÁ ÀÚ³à À¯¹« Á¤º¸°ø°³·Î ¿ª´ë±Þ ¹ÝÀü (2024-10-31)
ºñÁîÇ÷¹ÀÌ-ÇÑÁø°ü±¤, ±â¾÷¿ë ÃâÀå ¿ÃÀοø ¼­ºñ½º °øµ¿»ç¾÷ (2025-02-28)
GSK acquires efimosfermin, a Phase III-ready FGF21 analog, t... (2025-05-20)
°íü »êÈ­¹° ¿¬·áÀüÁö ½ÃÀå ¿¬Æò±Õ 25.1% ¼ºÀå (2023-06-04)
kate spade new york¡¯s Newest Campaign Starring Ice Spice an... (2025-05-31)
FDA Approves Gammagard Liquid ERC With Low IgA As First Read... (2025-07-12)
KBO ¿Ã½ºÅ¸Àü°ú Áñ±â´Â ¡®°¶·°½Ã Z Æúµå7¡¤Z Çø³7¡¯ üÇèÁ¸ ¿À... (2025-07-12)
±â¾Æ, ¡®´õ ±â¾Æ EV9 GT¡¯, ¡®½ºÅĴٵ塯 °è¾à °³½Ã (2025-02-19)
Çö´ëÂ÷±×·ì, »ç³» ½ºÅ¸Æ®¾÷ 4°³»ç ºÐ»ç (2025-03-13)
HCLTech Expands Partnership With The Standard to Accelerate ... (2025-06-25)
Ecolab Life Sciences Launches New Bioprocessing Purification... (2025-06-25)
11³â° À̾îÁö´Â ÇöÁ÷ÀÚ Àç´É±âºÎ ¸àÅ丵 (2025-03-07)
Thales Launches File Activity Monitoring (FAM) to Strengthen... (2025-07-09)
LG»ýȰ°Ç°­, ¹ßÀ»¾ÄÀÚ X ¯±¸´Â ¸ø¸»·Á Ä÷¡¹ö ¿¡µð¼Ç ·ÐĪ (2025-02-15)
±Á³×ġŲ, ¡®2024 ´ëÇѹα¹ µðÁöÅÐ ±¤°í ´ë»ó¡¯ 2°³ ºÎ¹® ¼ö»ó (2024-12-29)
MSCI Expands Private Assets Toolkit With Launch of Indexes T... (2025-05-05)
¹é·Éµµ ¹Ìµð¾î±³À°¡¦ ÇöÀå ±³À° ÅëÇÑ ¹Ìµð¾î ¸®ÅÍ·¯½Ã Çâ»ó (2025-06-22)
¿Â¹ö½º¸ðºô¸®Æ¼, ¹«ºê¿Í Àü·«Àû Á¦ÈÞ (2025-02-26)
µ¿¿ø±×·ì, ¿µ¾÷ÀÌÀÍ 8.4% Áõ°¡¡¦ ³»½Ç °æ¿µ ÅëÇß´Ù (2025-02-20)
       [ÀÌÀü][1]....[227][228][229][230][231][232][233][234][235]...[3704][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..